Follow Us TR

News Details

Fate Therapeutics Announces Exclusive License Agreement with Baylor College of Medicine for Rejection-resistant iPSC-derived Cellular Therapies

About Fate Therapeutics, Inc.
  • NASDAQ: $FATE
  • Notified: $33.75
  • 08:00 EDT

Price Chart